Gevo, Inc.  

(Public, NASDAQ:GEVO)   Watch this stock  
Find more results for gevo
0.620
+0.001 (0.16%)
Nov 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.59 - 0.62
52 week 0.53 - 6.98
Open 0.60
Vol / Avg. 193,289.00/861,229.00
Mkt cap 13.52M
P/E     -
Div/yield     -
EPS -1.75
Shares 21.81M
Beta 3.11
Inst. own 9%
Nov 6, 2017
Q3 2017 Gevo Inc Earnings Call - Webcast
Sep 11, 2017
Gevo Inc at Rodman & Renshaw Global Investment Conference
Sep 7, 2017
Gevo Inc at BEI AlphaDirect Virtual Conference Series
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -53.94% -136.80%
Operating margin -66.41% -109.76%
EBITD margin - -63.34%
Return on average assets -17.46% -34.61%
Return on average equity -24.86% -63.32%
Employees 74 -
CDP Score - -

Address

Building C, 345 Inverness Dr S Ste 310
ENGLEWOOD, CO 80112-5892
United States - Map
+1-303-8588358 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Gevo, Inc. (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.

Officers and directors

Ruth I. Dreessen Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Christopher Michael Ryan Ph.D. President, Chief Operating Officer, Chief Technology Officer
Age: 53
Bio & Compensation  - Reuters
Patrick R. Gruber Ph.D. Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Mike Willis Chief Financial Officer, Executive Vice President of Corporate Development and Strategy
Age: 45
Bio & Compensation  - Reuters
Brett K E Lund J.D. Chief Legal Officer, General Counsel, and Secretary
Age: 39
Bio & Compensation  - Reuters
Greg Roda Chief Commercial Officer
Age: 55
Bio & Compensation  - Reuters
William H. Baum Director
Age: 68
Bio & Compensation  - Reuters
Johannes Minho Roth Director
Bio & Compensation  - Reuters
Andy Marsh Independent Director
Age: 59
Bio & Compensation  - Reuters
Gary W. Mize Independent Director
Age: 64
Bio & Compensation  - Reuters